Norio Masumoto Selected Research

Norio Masumoto Research Topics

Disease

27	Breast Neoplasms (Breast Cancer) 05/2022 - 11/2011
11	Neoplasms (Cancer) 03/2022 - 12/2011
5	Triple Negative Breast Neoplasms 05/2022 - 11/2011
3	Neoplasm Metastasis (Metastasis) 09/2021 - 09/2014
3	Lymphatic Metastasis 11/2019 - 09/2013
2	Type 2 Diabetes Mellitus (MODY) 06/2017 - 03/2017
1	Microsatellite Instability 03/2022
1	Turcot syndrome 03/2022
1	Febrile Neutropenia 07/2021
1	Pathologic Complete Response 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2012
1	Shock 09/2012
1	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2012
1	Sepsis (Septicemia) 09/2012
1	Liver Failure 01/2009
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 09/2007

Drug/Important Bio-Agent (IBA)

5	Estrogen ReceptorsIBA 09/2021 - 09/2013
5	Phenobarbital (Luminal)FDA Link 05/2021 - 02/2015
4	ErbB Receptors (EGF Receptor)IBA 05/2022 - 05/2016
4	Trastuzumab (Herceptin)FDA Link 07/2021 - 11/2011
4	Biological ProductsIBA 05/2021 - 09/2013
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2021 - 04/2015
3	human ERBB2 proteinIBA 07/2021 - 09/2013
3	AlbuminsIBA 06/2017 - 09/2007
2	Pharmaceutical PreparationsIBA 09/2021 - 03/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 09/2021 - 04/2015
2	Estrogens (Estrogen)FDA Link 09/2021 - 09/2013
2	taxaneIBA 01/2018 - 04/2015
2	Hormones (Hormone)IBA 04/2015 - 10/2013
1	Immune Checkpoint InhibitorsIBA 03/2022
1	Biomarkers (Surrogate Marker)IBA 03/2022
1	pembrolizumabIBA 03/2022
1	Tamoxifen FDA LinkGeneric 09/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2021
1	Docetaxel (Taxotere)FDA Link 07/2021
1	Protein Isoforms (Isoforms)IBA 06/2020
1	Culture MediaIBA 06/2020
1	RNA (Ribonucleic Acid)IBA 06/2020
1	Transfer RNA (tRNA)IBA 06/2020
1	MicroRNAs (MicroRNA)IBA 06/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2019
1	Biological FactorsIBA 10/2019
1	Proteins (Proteins, Gene)FDA Link 04/2018
1	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 04/2018
1	AnthracyclinesIBA 01/2018
1	alogliptinIBA 06/2017
1	Dipeptidyl-Peptidase IV InhibitorsIBA 06/2017
1	perfluorobutane (AI 700)IBA 05/2016
1	Albumin-Bound Paclitaxel FDA Link 04/2015
1	Epirubicin (Ellence)FDA LinkGeneric 04/2015
1	Fluorouracil (Carac)FDA LinkGeneric 04/2015
1	cremophorIBA 04/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2013
1	Capecitabine (Xeloda)FDA Link 12/2011
1	Plasminogen Activators (Plasminogen Activator)IBA 09/2007
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 09/2007

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 03/2022 - 11/2011
5	Neoadjuvant Therapy 05/2022 - 04/2016
5	Therapeutics 03/2022 - 09/2012
2	Glycemic Control 06/2017 - 03/2017
1	Mastectomy (Mammectomy) 03/2022
1	Adjuvant Chemotherapy 07/2021
1	Simple Mastectomy 01/2019
1	Lymph Node Excision (Lymph Node Dissection) 09/2014
1	Segmental Mastectomy (Lumpectomy) 02/2013
1	Aftercare (After-Treatment) 09/2012
1	Transplantation 01/2009